Addition of immune checkpoint inhibitor to standard of care chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma: a systematic review and meta-analysis.
- DOI
- 10.37349/etat.2026.1002403
- Published
- 2026
- Container
- Exploration of targeted anti-tumor therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.37349/etat.2026.1002403,
title = {Addition of immune checkpoint inhibitor to standard of care chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma: a systematic review and meta-analysis.},
author = {Srinivasmurthy R and Ta J and Afifi S and Khalid T and Aboaid H and Nanda RK and Jones DT and Do K and Nguyen K and Fama K and Aamer S and Myat YM and Bigcas JL and Thein KZ},
year = {2026},
journal = {Exploration of targeted anti-tumor therapy},
doi = {10.37349/etat.2026.1002403},
url = {https://doi.org/10.37349/etat.2026.1002403}
}RIS
TY - JOUR TI - Addition of immune checkpoint inhibitor to standard of care chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma: a systematic review and meta-analysis. AU - Srinivasmurthy R AU - Ta J AU - Afifi S AU - Khalid T AU - Aboaid H AU - Nanda RK AU - Jones DT AU - Do K AU - Nguyen K AU - Fama K AU - Aamer S AU - Myat YM AU - Bigcas JL AU - Thein KZ PY - 2026 JO - Exploration of targeted anti-tumor therapy DO - 10.37349/etat.2026.1002403 UR - https://doi.org/10.37349/etat.2026.1002403 ER -
APA
R, S., J, T., S, A., T, K., H, A., RK, N., DT, J., K, D., K, N., K, F., S, A., YM, M., JL, B., & KZ, T. (2026). Addition of immune checkpoint inhibitor to standard of care chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma: a systematic review and meta-analysis.. Exploration of targeted anti-tumor therapy. https://doi.org/10.37349/etat.2026.1002403
Source records
- pubmed · retrieved 2026-11-10T11:51:23.135Z